SCHEMBL18200089

SCHEMBL18200089

Cc1ccc(S(N)(=O)=O)c(C)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 12/20 0.39
CA2 P00918 12/20 0.39
CA9 Q16790 10/20 0.39
CA12 O43570 9/20 0.39
CA14 Q9ULX7 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PDIA6 Q15084 1/20 0.37
CA6 P23280 4/20 0.37
CA7 P43166 3/20 0.37
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
CA3 P07451 1/20 0.37
MAPK1 P28482 1/20 0.36
BRD4 O60885 1/20 0.36
BRD2 P25440 1/20 0.36
BRD3 Q15059 1/20 0.36
GAA P10253 1/20 0.36
CCR1 P32246 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26442411 0.80 L3MBTL1 (0.41) ALDH1A1KDM4EGAACCR1RAB9A
SCHEMBL31028677 0.79 PTGS2 (0.38) CA1CA2CA9CA12CA14
SCHEMBL22867202 0.79 LDHA (0.41) CA1CA2CA9CA12ALDH1A1
SCHEMBL28667063 0.79 CA2 (0.37) CA1CA2CA9CA12CA14
SCHEMBL31028678 0.79 PTGS2 (0.38) CA1CA2CA9CA12CA14
SCHEMBL31028687 0.79 KMT2A (0.41) CA1CA2CA9CA12CA14
SCHEMBL31028711 0.79 PTGS2 (0.38) CA1CA2CA9CA12ALDH1A1
SCHEMBL8432927 0.78 MYC (0.36) ALDH1A1KDM4EGAACCR1RAB9A
SCHEMBL18200090 0.78 TRPV4 (0.36) ALDH1A1GAACCR1RAB9ACCR5
SCHEMBL27263647 0.77 GLO1 (0.35) CA1CA2CA9CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO claimed
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO disclosed
WO-2023134582-A1 PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF 上海立森印迹医药技术有限公司 2023-07-20 WO disclosed
WO-2016173493-A1 SULFONYLAMINOCARBONYL DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USES THEREOF SHANGHAI DE NOVO PHARMATECH CO. LTD. (CN) 2016-11-03 WO disclosed